StockData
LeMaitre Vascular Inc logo

LeMaitre Vascular Inc (LMAT) stock

LMATNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 22/3023% below fair value
$74.86−0.72 (-0.95%)

Close on Nov 19, 2026Market cap $1.71BP/E 26.3Yield 1.07%

LeMaitre Vascular free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

LeMaitre Vascular's free cash flow for the twelve months ending Jun 30, 2026 was $73.83M, up 41.1% year over year. For fiscal 2025 it was $74.47M, up 100.4% from the year before. Over ten years it grew 23.3% a year on average. The highest annual figure on record is $74.47M in fiscal 2025.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025$74.47M+100.4%
FY2024Dec 31, 2024$37.16M+26.0%
FY2023Dec 31, 2023$29.49M+33.1%
FY2022Dec 31, 2022$22.15M-26.7%
FY2021Dec 31, 2021$30.22M-5.0%
FY2020Dec 31, 2020$31.82M+205.4%
FY2019Dec 31, 2019$10.42M-36.7%
FY2018Dec 31, 2018$16.45M+0.0%
FY2017Dec 31, 2017$16.45M+17.0%
FY2016Dec 31, 2016$14.06M+53.4%
FY2015Dec 31, 2015$9.17M+111.3%
FY2014Dec 31, 2014$4.34M+63.4%
FY2013Dec 31, 2013$2.66M-24.4%
FY2012Dec 31, 2012$3.51M+205.7%
FY2011Dec 31, 2011$1.15M-74.9%
FY2010Dec 31, 2010$4.58M-5.8%
FY2009Dec 31, 2009$4.86M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$13.65M-28.0%
Q1 FY2026Mar 31, 2026$12.31M+60.8%
Q4 FY2025Dec 31, 2025$21.38M+62.7%
Q3 FY2025Sep 30, 2025$26.48M+110.6%
Q2 FY2025Jun 30, 2025$18.95M+144.6%
Q1 FY2025Mar 31, 2025$7.66M+106.9%
Q4 FY2024Dec 31, 2024$13.14M+38.8%
Q3 FY2024Sep 30, 2024$12.58M+16.8%
Q2 FY2024Jun 30, 2024$7.75M-14.9%
Q1 FY2024Mar 31, 2024$3.70M+2383.9%
Q4 FY2023Dec 31, 2023$9.47M+236.1%
Q3 FY2023Sep 30, 2023$10.77M+56.5%
Q2 FY2023Jun 30, 2023$9.10M+10.0%
Q1 FY2023Mar 31, 2023$149.00K-96.4%
Q4 FY2022Dec 31, 2022$2.82M-36.7%
Q3 FY2022Sep 30, 2022$6.88M-43.9%
Q2 FY2022Jun 30, 2022$8.28M-2.6%
Q1 FY2022Mar 31, 2022$4.18M-16.7%
Q4 FY2021Dec 31, 2021$4.45M-65.6%
Q3 FY2021Sep 30, 2021$12.26M-9.3%
Q2 FY2021Jun 30, 2021$8.49M+68.7%
Q1 FY2021Mar 31, 2021$5.02M+1438.3%
Q4 FY2020Dec 31, 2020$12.94M+208.5%
Q3 FY2020Sep 30, 2020$13.52M+259.5%
Q2 FY2020Jun 30, 2020$5.04M+44.5%
Q1 FY2020Mar 31, 2020$326.00K–
Q4 FY2019Dec 31, 2019$4.19M-20.6%
Q3 FY2019Sep 30, 2019$3.76M-0.4%
Q2 FY2019Jun 30, 2019$3.49M-14.4%
Q1 FY2019Mar 31, 2019-$1.02M-130.7%
Q4 FY2018Dec 31, 2018$5.28M+2.9%
Q3 FY2018Sep 30, 2018$3.77M-35.6%
Q2 FY2018Jun 30, 2018$4.07M-12.8%
Q1 FY2018Mar 31, 2018$3.32M+323.4%
Q4 FY2017Dec 31, 2017$5.13M+61.3%
Q3 FY2017Sep 30, 2017$5.86M–
Q2 FY2017Jun 30, 2017$4.67M–
Q1 FY2017Mar 31, 2017$785.00K–
Q4 FY2016Dec 31, 2016$3.18M–

More LeMaitre Vascular figures

See a number that looks wrong?